NCT04766073

Brief Summary

In the last decade we have been exposed to the complication of a caesarean section called a "niche". A niche is an anaerobic defect in the location of the cesarean section, which represents the discontinuity of the endometrium and myometrium. A niche is usually diagnosed by ultrasound, and can also be diagnosed by hysterosalpingogram or hysteroscopy. In the presence of a niche women suffer more frequently from irregular bleeding, dysmenorrhea, chronic pelvic pain, and dyspareunia. We believe that a combination of tissue ischemia and thinning of the scar tissue that forms, causes a niche to form. Large randomized studies regarding the preferred surgical technique in cesarean section, including various methods of incision closure have found that there is no single method that is obviously superior. However, these studies did not examine niche formation as a complication of cesarean section. In this study we will examine whether a unique incision closure method reduces post-cesarean niche formation.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
183

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 17, 2021

Completed
6 days until next milestone

First Posted

Study publicly available on registry

February 23, 2021

Completed
5 months until next milestone

Study Start

First participant enrolled

July 22, 2021

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2024

Completed
Last Updated

September 25, 2023

Status Verified

September 1, 2023

Enrollment Period

2.5 years

First QC Date

February 17, 2021

Last Update Submit

September 22, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Formation of a uterine niche

    Presence of a uterine niche on ultrasound

    At least 12 weeks after delivery.

Secondary Outcomes (5)

  • Duration of surgery

    At surgery

  • Blood loss over 1000 mL

    At surgery

  • Postoperative infection

    Up to 6 weeks after intervention

  • Need for repeat laparotomy

    Up to 6 weeks after intervention

  • Formation of a n abscess/hematoma

    Up to 6 weeks after intervention

Study Arms (2)

New Closure Technique

EXPERIMENTAL

This group will have the uterus closed after delivery of the fetus during cesarean section with a new technique.

Procedure: Niche prevention suture

Regular closure technique

NO INTERVENTION

The usual method of closing the surgical incision is to suture the entire wall of the uterus with a stratafix suture without locking the suture.

Interventions

This group will have the uterus sutured in two layers using a new technique.

New Closure Technique

Eligibility Criteria

Age17 Years - 50 Years
Sexfemale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Women at first cesarean delivery
  • Women who consent to the study

You may not qualify if:

  • Women who are having a repeat caesarean section
  • Refusal to participate in the study
  • Urgent or emergent cesarean delivery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hadassah Medical Organization

Jerusalem, Israel

RECRUITING

MeSH Terms

Conditions

Uterine Hemorrhage

Condition Hierarchy (Ancestors)

Uterine DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesHemorrhagePathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Hila Hochler, MD

    Hadassah Medical Organization

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Hadas Lemberg, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 17, 2021

First Posted

February 23, 2021

Study Start

July 22, 2021

Primary Completion

February 1, 2024

Study Completion

February 1, 2024

Last Updated

September 25, 2023

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will not share

Locations